Javascript must be enabled to continue!
Reflex single-gene non-invasive prenatal testing significantly increases the cost-effectiveness of carrier screening
View through CrossRef
Abstract
Objective
To evaluate the clinical and cost savings benefits of adoption of a carrier screen with reflex single-gene non-invasive prenatal test (sgNIPT) in prenatal care.
Method
A decision-analytic model was developed to compare carrier screen with reflex sgNIPT (maternal carrier status and fetal risk reported together) as first-line carrier screening to the traditional carrier screening workflow (positive maternal carrier screen followed by paternal screening to evaluate fetal risk). The model compared the clinical outcomes and cost effectiveness between the two screening methods. These results were used to simulate appropriate pricing for reflex sgNIPT.
Results
Reflex sgNIPT carrier screening detected 108 of 110 affected pregnancies per 100,000 births (98.5% sensitivity), whereas traditional carrier screening detected 46 of 110 affected pregnancies (41.5% sensitivity). The cost to identify one affected pregnancy was reduced by 62% in the reflex sgNIPT scenario compared to the traditional scenario. Adding together the testing cost savings and the savings from earlier clinical intervention made possible by reflex sgNIPT, the total cost savings was $37.6 million per 100,000 pregnancies. Based on these cost savings, we simulated appropriate reflex sgNIPT pricing range: if the cost to identify one affected pregnancy is the unit cost, carrier screening with reflex sgNIPT can be priced up to $1,859 per test (or $7,233 if sgNIPT is billed separately); if the cost per 100,000 pregnancies is the unit cost, carrier screening with sgNIPT can be priced up to $1,070 per test (or $2,336 if sgNIPT is billed separately).
Conclusion
Using the carrier screen with reflex sgNIPT as first-line screening improves the detection of affected fetuses by 2.4-fold and can save costs for the healthcare system. A real-life experience will be needed to assess the clinical utility and exact cost savings of carrier screen with reflex sgNIPT.
Title: Reflex single-gene non-invasive prenatal testing significantly increases the cost-effectiveness of carrier screening
Description:
Abstract
Objective
To evaluate the clinical and cost savings benefits of adoption of a carrier screen with reflex single-gene non-invasive prenatal test (sgNIPT) in prenatal care.
Method
A decision-analytic model was developed to compare carrier screen with reflex sgNIPT (maternal carrier status and fetal risk reported together) as first-line carrier screening to the traditional carrier screening workflow (positive maternal carrier screen followed by paternal screening to evaluate fetal risk).
The model compared the clinical outcomes and cost effectiveness between the two screening methods.
These results were used to simulate appropriate pricing for reflex sgNIPT.
Results
Reflex sgNIPT carrier screening detected 108 of 110 affected pregnancies per 100,000 births (98.
5% sensitivity), whereas traditional carrier screening detected 46 of 110 affected pregnancies (41.
5% sensitivity).
The cost to identify one affected pregnancy was reduced by 62% in the reflex sgNIPT scenario compared to the traditional scenario.
Adding together the testing cost savings and the savings from earlier clinical intervention made possible by reflex sgNIPT, the total cost savings was $37.
6 million per 100,000 pregnancies.
Based on these cost savings, we simulated appropriate reflex sgNIPT pricing range: if the cost to identify one affected pregnancy is the unit cost, carrier screening with reflex sgNIPT can be priced up to $1,859 per test (or $7,233 if sgNIPT is billed separately); if the cost per 100,000 pregnancies is the unit cost, carrier screening with sgNIPT can be priced up to $1,070 per test (or $2,336 if sgNIPT is billed separately).
Conclusion
Using the carrier screen with reflex sgNIPT as first-line screening improves the detection of affected fetuses by 2.
4-fold and can save costs for the healthcare system.
A real-life experience will be needed to assess the clinical utility and exact cost savings of carrier screen with reflex sgNIPT.
Related Results
The feasibility of risk-stratified screening as routine practice in the NHS Breast Screening Programme in England: the PROCAS2 research programme
The feasibility of risk-stratified screening as routine practice in the NHS Breast Screening Programme in England: the PROCAS2 research programme
Background
Screening for breast cancer produces benefits through cancers being detected earlier, thereby reducing premature deaths and the need for more intensi...
Reflex System for Intelligent Robotics
Reflex System for Intelligent Robotics
Background and Purpose: Great advances have occurred in the field of robotics in the past few years. The integration of robotics in our daily life became not only limited to manufa...
Operant down-conditioning of the soleus H-reflex in people after stroke
Operant down-conditioning of the soleus H-reflex in people after stroke
Through operant conditioning, spinal reflex behaviors can be changed. Previous studies in rats indicate that the sensorimotor cortex and corticospinal tract are essential in induci...
Genetic Carrier Testing and Screening
Genetic Carrier Testing and Screening
Abstract
Genetic carrier testing involves testing for the heterozygous status of a recessively inherited disorder in individuals ...
Prenatal Yoga terhadap Pengurangan Kecemasan Ibu Hamil
Prenatal Yoga terhadap Pengurangan Kecemasan Ibu Hamil
Abstract:
Background: Pregnancy takes place physiological and psychological changes cause pregnant women to experience anxiety. If left untreated it can lead to pregnancy and chi...
Genetic Carrier Testing
Genetic Carrier Testing
Abstract
Genetic carrier testing includes tests for the heterozygous status of a recessively inherited disorder in individuals wh...
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Abstract
Epidemiologic studiessuggested the association between prenatal Di-(2-ethylhexyl) phthalate (DEHP) exposure and disorders of sex development (DSD), adult male diso...
CLINICAL AUDIT ON REFLEXFREE T3 TESTING AT HOSPITAL PUTRAJAYA, MALAYSIA
CLINICAL AUDIT ON REFLEXFREE T3 TESTING AT HOSPITAL PUTRAJAYA, MALAYSIA
INTRODUCTIONReflex-free T3 (fT3) testing has long been used to optimize the use of laboratory tests in Hospital Putrajaya. It involves the automatic addition of fT3 reflexively whe...

